Evaluating the effect of Gabapentin in improving symptoms of functional dyspeptic patients resistant to routine treatments

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20120709010222N19

Enrollment

126

Registered

2018-09-18

Start date

2018-09-23

Completion date

Unknown

Last updated

2018-10-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dyspepsia. Functional dyspepsia

Interventions

Intervention 1: Intervention group:In addition to 20 mg omeprazole,receive 300 mg of gabapentin is given twice a day. Intervention 2: Control group: only receive routine treatment, that is, daily 20

Eligibility

Sex/Gender

All

Age

40 Years to 60 Years

Inclusion criteria

Inclusion criteria: Confirmation of functional dyspepsia diagnosis

Exclusion criteria

Exclusion criteria: Sensitivity to gabapentin, Serious side effect of gabapentin

Design outcomes

Primary

Measure	Time frame
Gastrointestinal symptoms. Timepoint: Four weeks later. Method of measurement: questionaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammadhadi Shafigh

Shahre-kord University of Medical Sciences

Mhshafigh@skums.ac.ir+98 38 3222 0016

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026